melarsoprol
Selected indexed studies
- Melarsoprol Resistance in African Trypanosomiasis. (Trends Parasitol, 2018) [PMID:29705579]
- Melarsoprol-cyclodextrins inclusion complexes. (Int J Pharm, 2005) [PMID:16253447]
- Slow-release melarsoprol microparticles. (Int J Pharm, 2002) [PMID:12176304]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Melarsoprol Resistance in African Trypanosomiasis. (2018) pubmed
- Melarsoprol-cyclodextrins inclusion complexes. (2005) pubmed
- Slow-release melarsoprol microparticles. (2002) pubmed
- [Melarsoprol]. (1999) pubmed
- Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. (2013) pubmed
- Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. (2003) pubmed
- Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma. (2023) pubmed
- Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association. (2020) pubmed
- Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis. (2011) pubmed
- Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. (2001) pubmed